Health officials in the UK have raised concerns about the reputational implications of a £330m contract with AI firm Palantir, impacting the implementation of an AI data platform for the NHS.
Health officials within the UK have expressed significant concerns regarding the reputational risks associated with a £330 million contract the NHS has with Palantir, a US surveillance technology company. These fears were highlighted in briefings obtained by The Guardian, particularly in light of Palantir's associations with high-profile controversial entities, which may impede the swift rollout of the essential AI-enabled data platform designed to streamline and connect disparate health information throughout the NHS. The concerns have emerged alongside political pressures from opposition leader Keir Starmer, who is advocating for a more rapid deployment of digital health tools.
